Michel Moise Habib
Direktor/Vorstandsmitglied bei EPITOMEE MEDICAL LTD
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Shaul Shohat | M | - |
BioProtect Ltd.
 BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | 20 Jahre |
| Ruthie Amir | M | 58 | 6 Jahre | |
| Moshik Cohen-Kutner | M | - |
Omnix Medical Ltd.
 Omnix Medical Ltd. Pharmaceuticals: MajorHealth Technology Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel. | 9 Jahre |
| Ishay Attar | M | - |
Eximore Ltd.
 Eximore Ltd. Medical SpecialtiesHealth Technology Eximore Ltd. develops an ophthalmic medical device. The company was founded by Ishay Attar and Izhar Halahmi in 2014 and is headquartered in Jerusalem, Israel. | 10 Jahre |
| Rafael Beyar | M | - |
Alive Israel Healthtech Fund
 Alive Israel Healthtech Fund Investment ManagersFinance Alive israel Healthtech Fund (Alive) is a venture capital firm founded in 2020 by Rafael Beyar, Michel Habib, Ari Shamiss and Dudi Klein. The firm is headquartered in Tel Aviv, Israel. | - |
| Izhar Halahmi | M | - |
Eximore Ltd.
Eximore Ltd. Medical SpecialtiesHealth Technology Eximore Ltd. develops an ophthalmic medical device. The company was founded by Ishay Attar and Izhar Halahmi in 2014 and is headquartered in Jerusalem, Israel. | 10 Jahre |
| Dudi Klein | M | - |
Alive Israel Healthtech Fund
Alive Israel Healthtech Fund Investment ManagersFinance Alive israel Healthtech Fund (Alive) is a venture capital firm founded in 2020 by Rafael Beyar, Michel Habib, Ari Shamiss and Dudi Klein. The firm is headquartered in Tel Aviv, Israel. | 4 Jahre |
| Yafit Stark | M | 71 |
Omnix Medical Ltd.
Omnix Medical Ltd. Pharmaceuticals: MajorHealth Technology Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel. | - |
| Ronit Tahel Koren | M | 56 | 2 Jahre | |
| Esther Noa Barak Landes | F | 58 | 2 Jahre | |
| Maya Gabrieli | F | 39 | 4 Jahre | |
| Niv Bachnoff | M | - |
Omnix Medical Ltd.
Omnix Medical Ltd. Pharmaceuticals: MajorHealth Technology Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel. | 9 Jahre |
| Ari Shamiss | M | 65 |
Alive Israel Healthtech Fund
Alive Israel Healthtech Fund Investment ManagersFinance Alive israel Healthtech Fund (Alive) is a venture capital firm founded in 2020 by Rafael Beyar, Michel Habib, Ari Shamiss and Dudi Klein. The firm is headquartered in Tel Aviv, Israel. | 4 Jahre |
| Aron M. Knickerbocker | M | 54 |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | 4 Jahre |
| Shimon Eckhouse | M | 79 | 19 Jahre | |
| Assaf Dekel | M | - |
BioProtect Ltd.
BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | - |
| Tamar Raz | M | 60 |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | 10 Jahre |
| Doron Nevo | M | 68 | 6 Jahre | |
| Merav Kaye | F | 51 |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | - |
| Gil Cohen | M | 61 | 6 Jahre | |
| Rom Lakritz | M | - |
Omnix Medical Ltd.
Omnix Medical Ltd. Pharmaceuticals: MajorHealth Technology Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel. | 9 Jahre |
| Yaron Pereg | M | - |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | 7 Jahre |
| Ori Chochen | M | - |
Omnix Medical Ltd.
Omnix Medical Ltd. Pharmaceuticals: MajorHealth Technology Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel. | - |
| Jennifer Minai-Azary | F | 46 |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | 2 Jahre |
| Ariel Moses | M | - | - | |
| Doron Lev Rozenblum | M | 54 | 2 Jahre | |
| Michal Geva | F | - |
BioProtect Ltd.
BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | - |
| Alex Jurovitsky | M | 75 |
BioProtect Ltd.
BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | - |
| Dan Hashimshony | M | 58 | 6 Jahre | |
| Gur Roshwalb | M | 55 |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | 3 Jahre |
| Donna J. Edmonds | F | - |
BioProtect Ltd.
BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | - |
| Yoav Moshe Sebba | M | 53 | 5 Jahre | |
| Eyal Lifschitz | M | - |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | - |
| Gal Aharonowitz | M | 61 | 4 Jahre | |
| Carl-Johan Spak | M | 68 |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | 7 Jahre |
| Israel Schreiber | M | - |
Ornim Medical Ltd.
 Ornim Medical Ltd. Medical SpecialtiesHealth Technology Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel. | 12 Jahre |
| Tal Menipaz | M | 55 |
BioProtect Ltd.
BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | - |
| Abraham Domb | M | - |
BioProtect Ltd.
BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | 20 Jahre |
| Irit Yaniv | M | 59 |
BioProtect Ltd.
BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | - |
| Michael Eden | M | 55 | 4 Jahre | |
| Thomas Bengt Eldered | M | 64 |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | - |
| Zeev Zehavi | M | - |
Alive Israel Healthtech Fund
Alive Israel Healthtech Fund Investment ManagersFinance Alive israel Healthtech Fund (Alive) is a venture capital firm founded in 2020 by Rafael Beyar, Michel Habib, Ari Shamiss and Dudi Klein. The firm is headquartered in Tel Aviv, Israel. | - |
| Safi Landskroner | F | 55 | 2 Jahre | |
| Yael Kenen | M | 61 | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ronen Nakash | M | - |
Technion-Israel Institute of Technology
| 16 Jahre |
| Miki Elad | M | - |
Technion-Israel Institute of Technology
| 6 Jahre |
| Avi Strum | M | 62 |
Technion-Israel Institute of Technology
| 8 Jahre |
| Guy Yachin | M | 55 |
Technion-Israel Institute of Technology
| 6 Jahre |
| Tal Raz Peretz | M | 62 | 3 Jahre | |
| Michal Sapir | F | 66 | 10 Jahre | |
| Joel Brand | M | - |
Technion-Israel Institute of Technology
| 9 Jahre |
| Agnes Le Saux-Narjoz | F | - |
Sensimed SA
 Sensimed SA Medical SpecialtiesHealth Technology Sensimed SA develops non-invasive soft contact lens-based solutions. It offers solutions to monitor fluctuations in intraocular pressure continuously. The company was founded by Matteo Leonardi and Sacha Cerboni in 2003 and is headquartered in Lausanne, Switzerland. | 7 Jahre |
| Meir Shmouely | M | 58 |
Technion-Israel Institute of Technology
| 6 Jahre |
| Avishay Katz | M | 66 |
Technion-Israel Institute of Technology
| 7 Jahre |
| Eyal Waldman | M | 63 |
Technion-Israel Institute of Technology
| 6 Jahre |
| Gadi Lenz | M | - |
Technion-Israel Institute of Technology
| 6 Jahre |
| Gil Allon | M | 59 |
Technion-Israel Institute of Technology
| 6 Jahre |
| Yuval Neeman | M | - |
Technion-Israel Institute of Technology
| 8 Jahre |
| Yuval Mika | M | 66 |
Technion-Israel Institute of Technology
| 9 Jahre |
| Shosh Merchav | M | - |
Technion-Israel Institute of Technology
| 16 Jahre |
| Eliezer Lavy | M | 58 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Yoav Hochberg | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Gilad Har Oz | M | 53 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Tsachi Czaczkes | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Michael Zissman | M | 57 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Oren Zeev | M | 59 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Eyal Gruner | M | 65 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Amir Lerman | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Shlomo Matityaho | M | 62 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Dany Eshchar | M | 65 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Shmuel Assa | M | 55 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Omri Toppol | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Inbal Kreiss | F | 57 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Roy Livneh | M | 52 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Dganit Vered | F | 57 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Fadi Swidan | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Gideon Yampolsky | M | 62 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Amit Segev | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Sasson Bar-Moshe | M | 60 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Boaz Chalamish | M | - |
Technion-Israel Institute of Technology
| 3 Jahre |
| Pinhas Buchris | M | - |
Technion-Israel Institute of Technology
| 3 Jahre |
| Orey Gilliam | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Bryan Jennings | M | - |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | 1 Jahre |
| Uri Feldman | M | 63 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Boaz Dinte | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Yuval Zuk | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Adi Gan | M | - |
Technion-Israel Institute of Technology
| 3 Jahre |
| Nelson Nahum | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Gilad Rosenberg | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Amram Peretz | M | 66 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Gal Hayut | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Pini Lozowick | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Eitan Shabtay | M | 54 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Yuval Berger | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Uzi Zangi | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Hezi Erez | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Izhar Shay | M | 60 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Jacques Benkoski | M | - |
Technion-Israel Institute of Technology
| 4 Jahre |
| Nir Wolf | M | 58 |
Technion-Israel Institute of Technology
| 4 Jahre |
| Batia Tocatly | F | - |
Technion-Israel Institute of Technology
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Israel | 99 | 99,00% |
| Schweiz | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michel Moise Habib
- Persönliches Netzwerk
